Atlas Trials

Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects

Clinical trial NCT07704944 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07704944
Sponsor
Chang Gung Memorial Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prediabetes
Start date
2026-07-01
Primary completion
2027-07-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.